publication venue for
- The role of brachytherapy in treatment of stage I esophageal cancer: A systematic review. 21:877-886. 2022
- Review of brachytherapy complications – Upper gastrointestinal tract. 20:1005-1013. 2021
- Substantial lymphovascular space invasion predicts worse outcomes in early-stage endometrioid endometrial cancer. 20:527-535. 2021
- Feasibility of an MRI-only workflow for postimplant dosimetry of low-dose-rate prostate brachytherapy: Transition from phantoms to patients. 18:863-874. 2019
- MRI-Only Post Implant Dosimetry Process for Prostate LDR Brachytherapy. 18:S70-S71. 2019
- MRI-Based Post-Implant Dosimetry of Prostate Brachytherapy Seeds. 17:S73-S74. 2018
- Moving toward uniform and evidence-based practice of radiotherapy for management of cervical cancer in Ontario, Canada. 17:660-666. 2018
- Endobronchial brachytherapy for metastasis from extrapulmonary malignancies as an effective treatment for palliation of symptoms. 16:630-638. 2017
- Prospective comparison of rectal dose reduction during intracavitary brachytherapy for cervical cancer using three rectal retraction techniques. 15:450-455. 2016
- Current Adjuvant Brachytherapy Practice for Endometrial Cancer in Ontario, Canada. 15:S100-S100. 2016
- Outcomes of Stage IA Serous Endometrial Adenocarcinoma. 15:S111-S112. 2016
- Post-Implant Visualization of the Prostate Brachytherapy Seeds and Calcifications Using Quantitative MR Techniques: T2, T2* and PD Mapping. 15:S183-S183. 2016
- A prospective analysis of high-dose-rate endobronchial brachytherapy in the palliation of obstructive symptoms in lung cancer patients: A single-institution experience. 14:655-661. 2015
- Endotracheal brachytherapy alone: An effective palliative treatment for tracheal tumors. 14:543-548. 2015
- Current State of External Beam Radiation Therapy and Brachytherapy for Cervix Cancer in Ontario. 13:S61-S61. 2014
- Saddle block analgesia for high-dose-rate brachytherapy: A prospective study. 8:335-338. 2009
- Endoscopic brachytherapy for obstructive colorectal cancer. 8:313-317. 2009
- Automated 2D/3D registration algorithm for high-dose-rate lung brachytherapy. 8:129-130. 2009
- The design and dosimety of a four-channel cylinder for treatment of endometrial cancer with high-dose-rate brachytherapy using the varisource afterloader. 8:154-155. 2009
- The effect of obesity on rectal dosimetry after permanent prostate brachytherapy. 8:218-222. 2009
- The variance of bladder and rectal doses calculated from orthogonal and simple stereo films in cervix high-dose-rate brachytherapy. 6:304-310. 2007
- The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry. 6:173-179. 2007
- Penile brachytherapy: Results for 60 patients. 6:82-82. 2007
- The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry. 6:105-105. 2007
- The role of high-dose-rate brachytherapy in the palliation of symptoms in patients with non–small-cell lung cancer: A systematic review. 5:189-202. 2006
- Radiation dose to the internal pudendal arteries from permanent seed prostate brachytherapy as determined by time-of-flight angiography. 5:78-78. 2006
- Relationship of the International Prostate Symptom score with urinary flow studies, and catheterization rates following 125I prostate brachytherapy. 5:9-13. 2006
- Robotically assisted prostate brachytherapy with transrectal ultrasound guidance—Phantom experiments. 5:14-26. 2006
- Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer. 3:191-195. 2004
- The utility of transition zone index in predicting acute urinary morbidity after 125I prostate brachytherapy. 1:131-137. 2002